Mission ...

The purpose of the Firestone Institute for Respiratory Health is to conduct research to increase understanding of respiratory health and disease across the life cycle through collaborative basic and clinical investigation with the eventual outcome of improving patient care.

We train young investigators to become independent researchers, encourage partnerships across disciplines nationally and internationally and create synergies with the public and private sectors.

Disclaimer and Web Site Use Policy

Site best viewed with newer browsers that permit CSS and use common Javascript conventions.

FIRESTONE Research
50 Charlton Avenue East
Hamilton Ontario
Canada L8N 4A6

905.522.1155 x33140

Firestone Institute for Respiratory Health

world_leader

Discovery

scope

Education

boxsymposium

 

Mentorship

student_computer

student_bench

 

Clinical Care

baby_whiteheadraquel_testing

Clinical Trials

inhaler

 

Symposium

people_symposiumTeach_001

Firestone Institute for Respiratory Health

badge_logoSince its inception as the Firestone Regional Chest and Allergy Unit (FRCAU) in 1978, the Firestone Institute for Respiratory Health (FIRH) has developed from, and continues to be, a clinical facility with strong research directions. The clinical component handles the majority of consultations for respiratory disease in Hamilton and its region. This ensures that the research questions being asked and answered have an important and practical clinical focus. FIRH is located in a purpose built new facility at St. Joseph’s Hospital. Its faculty comprises a collegial mix of clinician-educators, clinician-scientists and basic researchers working in close proximity, which again helps to facilitate the research agenda.

Notable achievements by FIRH scientists in the respiratory field include:

  • FIRH methodologies have become the international standard in the development of indirect methods to study airway inflammation by non-invasive techniques.
  • Firestone scientists developed the most widely used methods of bronchial provocations using inhaled histamine, methacholine and allergens.
  • The Aerochamberâ„¢ valved holding chamber for MDI aerosols, used internationally to improve delivery of inhaled medication, was developed by FIRH faculty.
  • Firestone scientists (in 1989) developed the first Canadian guidelines for the treatment of asthma; these subsequently had a significant impact on the development of international guidelines.
  • FIRH scientists fostered and coordinated the development of the national birth-cohort collaboration leading to the CIHR-funded Canadian Healthy Infant Longitudinal Development (CHILD) study, whose central administration is at FIRH.

 

Firestone Clinic
St. Joseph's Healthcare
50 Charlton Avenue East
Hamilton, Ontario
Canada L8N 4A6
www.FIRH.ca

905.522.1155 x36000

 

Faculty

Dr. Paul O'Byrne

  • Dr. Malcolm Sears
  • Dr. Gerard Cox
  • Dr. Chris Allen
  • Dr. Frederick Hargreave
  • Dr. Parameswaran Nair
  • Dr. Andrew McIvor
  • Dr. Mark Larche
  • Dr. Luke Janssen
  • Dr. Martin Kolb
  • Dr. Mark Inman
  • Dr. Roma Sehmi
  • Dr. Renee Labiris
  • Mr. Neil Johnston
  • Ms. Myrna Dolovich
  • Dr. David Todd
  • Dr. Mark Soth
  • Dr. Helen Ramesdale
  • Dr. Stewart Pugsley
  • Dr. Lori Whitehead
  • Dr. Nicole Drost
  • Mr. Michael Quinn